Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1993; 22:598-606
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takaoka, H
Right arrow Articles by Yokoyama, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takaoka, H
Right arrow Articles by Yokoyama, M

Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseases human heart

H Takaoka, M Takeuchi, M Odake, Y Hayashi, M Mori, K Hata, and M Yokoyama

1st Department of Internal Medicine, Kobe University School of Medicine, Japan.

OBJECTIVES. The aim of this study was to compare the effects of a phosphodiesterase inhibitor and catecholamine on arterial-ventricular coupling and myocardial energetics in the diseases human heart. BACKGROUND. Recent experimental studies have indicated that the arterial-ventricular coupling analysis using the time-varying elastance model could discriminate between inotropic and vasoactive effects of the two agents. METHODS. With the use of a conductance catheter, left ventricular contractility and arterial afterload were measured from the slope of the end-systolic pressure-volume relation, Emax, and the slope of the end-systolic pressure-stroke volume relation, Ea. Arterial-ventricular coupling was assessed by Ea/Emax before and after administration of a new phosphodiesterase inhibitor, E-1020 (0.3 microgram/kg per min), and a beta 1-stimulant, dobutamine (5 micrograms/kg per min), in 20 patients with heart disease. Left ventricular mechanical efficiency was assessed as the ratio of stroke work to myocardial oxygen consumption per beat measured by the thermodilution method. RESULTS. The slope of the end-systolic pressure-volume relation increased comparably with both E-1020 (39%, p < 0.01) and dobutamine (47%, p < 0.01), but Ea/Emax decreased with E-1020 (1.25 to 0.78, -37%, p < 0.01) more than with dobutamine (1.23 to 0.99, -16%, p < 0.05). Although stroke work index increased with both agents, myocardial oxygen consumption remained unchanged with E-1020 but increased with dobutamine (p < 0.05). Consequently, left ventricular mechanical efficiency increased with E-1020 (0.30 to 0.36, p < 0.05) but remained unchanged with dobutamine (0.27 to 0.29, p = NS). CONCLUSIONS. The phosphodiesterase inhibitor E-1020 improved arterial-ventricular coupling more than did dobutamine, with a resultant increase in mechanical efficiency. These data were in accordance with the theoretic prediction of the coupling analysis in the diseases human heart.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Morimont, B. Lambermont, A. Ghuysen, P. Gerard, P. Kolh, P. Lancellotti, V. Tchana-Sato, T. Desaive, and V. D'Orio
Effective arterial elastance as an index of pulmonary vascular load
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2736 - H2742.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Takahashi, S. Cho, T. Hara, H. Ureshino, S. Tomiyasu, and K. Sumikawa
The Interaction of MCI-154, a Calcium Sensitizer, and Isoflurane on Systemic and Coronary Hemodynamics in Chronically Instrumented Dogs
Anesth. Analg., January 1, 2004; 98(1): 30 - 36.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Nagata, Y. Kakihana, K. Tobo, S. Isowaki, and Y. Kanmura
The Effects of Olprinone (a Phosphodiesterase III Inhibitor) on Hepatic Vascular Bed in a Porcine Model of Endotoxemia
Anesth. Analg., March 1, 2001; 92(3): 676 - 680.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. W. Wallace, M. B. Ratcliffe, P. S. Nose, W. Bellows, W. Moores, M. T. McEnany, K. Flachsbart, and D. T. Mangano
Effect of induction and reperfusion with warm substrate-enriched cardioplegia on ventricular function
Ann. Thorac. Surg., October 1, 2000; 70(4): 1301 - 1307.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. H. Devlin, J. Petrusha, K. Briesmiester, D. Montgomery, and M. R. Starling
Impact of Vascular Adaptation to Chronic Aortic Regurgitation on Left Ventricular Performance
Circulation, March 2, 1999; 99(8): 1027 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Ochiai, S. Morita, Y. Tanoue, Y. Kawachi, R. Tominaga, and H. Yasui
Use of transesophageal echocardiography for postoperative evaluation of right ventricular function
Ann. Thorac. Surg., January 1, 1999; 67(1): 146 - 152.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Ochiai, S. Morita, Y. Tanoue, Y. Kawachi, R. Tominaga, and H. Yasui
Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations
J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 139 - 147.
[Abstract] [Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement